Adjuvant fractionated radiotherapy significantly improves DFS in patients with atypical meningioma who have undergone complete surgical resection By Ogkologos - October 8, 2026 16 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the ROAM/EORTC-1308 study Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Granting a Marketing Authorisation for Ensartinib Taking on the RAS Challenge ESMO Calls for the European Commission to Propose an EU Directive on Psychosocial Risks (PSR) at Work to Protect the Oncology Workforce MOST POPULAR Prising open the trap: Getting to grips with targeted cancer drug... January 10, 2022 ESMO Strengthens Global Oncology Collaboration Through its Growing Presence in the... June 12, 2026 Implementation of Molecular Tumour Board Portal Developed Under the Umbrella of... May 25, 2022 Oligoprogression in Metastatic NSCLC Could Be Effectively Treated with SBRT Plus... December 21, 2023 Load more HOT NEWS A Diagnosis of Advanced Lung Cancer Is Not a Death Sentence New Approach Uses Much Less Tissue to Analyze Tumor Proteins and... EMA’s Safety Committee Has Concluded That the Benefits of Ifosfamide Solutions... Cancer Surgery Unexpectedly Canceled for Mother of Two, Who Says It’s...
